Prognostic significance of syndecan-1 expression in cervical cancers
Authors:
Open Access
- 1 January 2011
- journal article
- Published by Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy in Journal of Gynecologic Oncology
- Vol. 22 (3) , 161-167
Abstract
Kim YI, et al. J Gynecol Oncol. 2011 Sep;22(3):161-167. http://dx.doi.org/10.3802/jgo.2011.22.3.161Keywords
This publication has 28 references indexed in Scilit:
- Human papillomavirus oncoproteins: pathways to transformationNature Reviews Cancer, 2010
- Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor κBGynecologic Oncology, 2009
- Distribution and Clinical Significance of Heparan Sulfate Proteoglycans in Ovarian CancerClinical Cancer Research, 2004
- Molecular interactions of syndecans during developmentSeminars in Cell & Developmental Biology, 2001
- Frequent activating mutations of FGFR3 in human bladder and cervix carcinomasNature Genetics, 1999
- Functions of Cell Surface Heparan Sulfate ProteoglycansAnnual Review of Biochemistry, 1999
- Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcomeThe Journal of Pathology, 1998
- Reduced expression of syndecan‐1 in human hepatocellular carcinoma with high metastatic potentialInternational Journal of Cancer, 1997
- Heparan sulfate proteoglycan expression in human lung-cancer cellsInternational Journal of Cancer, 1997
- The Role of Syndecan-1 in MalignanciesAnnals of Medicine, 1996